Skip to main content
Cardiolucent

Service

Guideline-Directed Medical Therapy (GDMT) for Cardiovascular Disease

Assessments & Care Plans

Guideline-Directed Medical Therapy (GDMT) is the set of medications proven by large clinical trials to extend life and prevent hospitalizations in cardiovascular disease. The benefit comes not just from being on a drug, but from being on the right combination at the right target dose — and most patients are technically on "a" regimen without being on an optimal one. Dr. Kedan's job is to close that gap, patient by patient, visit by visit, until you're on the most protective combination you can tolerate.

What's Included

  • Heart failure optimization — ACE/ARB/ARNI, beta-blockers, MRAs, SGLT2 inhibitors
  • Coronary artery disease and post-stent/post-bypass regimen management
  • Atrial fibrillation rate, rhythm, and anticoagulation strategy
  • Hypertension regimen built against current ACC/AHA targets
  • Secondary prevention after myocardial infarction
  • Careful titration with lab monitoring for kidney function, potassium, and tolerance
  • Plain-language patient education on the why behind each medication

How This Helps You

Real-world data consistently show that fully optimized GDMT meaningfully reduces hospitalizations and mortality compared with partial regimens. The gap between "on a medication" and "on the right combination at target dose" is where most of the preventable risk lives. Closing it requires unhurried titration, frequent labs, and a physician who actually adjusts the regimen rather than copying it forward.

Who This Is For

  • Patients with heart failure (preserved or reduced ejection fraction)
  • Patients with coronary artery disease, post-stent, or post-bypass
  • People with atrial fibrillation needing rate, rhythm, and anticoagulation strategy
  • Patients recovering from a heart attack and needing secondary prevention
  • People on a long-running cardiac regimen who haven't been re-evaluated against current guidelines
  • Patients who've experienced side effects and need an alternative within the same GDMT class
  • Anyone whose current regimen feels like a list rather than a plan

What to Expect at Your Visit

The initial visit runs 60+ minutes — full cardiovascular history, focused exam, POCUS, EKG, and review of every current medication against the latest guidelines. Titration usually takes weeks to a few months, with dose increases every 1–2 weeks when tolerated and labs rechecked along the way. The concierge model accelerates this: dose changes don't have to wait for the next available slot, and questions get answered the same day.

Why Cardiolucent

GDMT optimization is the textbook case for concierge cardiology. It requires direct physician access during titration, fast labs, and willingness to actually keep adjusting until the patient is at goal — none of which fits in a 15-minute follow-up. Dr. Kedan personally handles every titration step and reviews the regimen at every visit, so the plan keeps reflecting your current physiology rather than the version of you from three years ago. Cedars-Sinai affiliation supports advanced heart failure care when needed.

Common Questions

Frequently Asked Questions

What is Guideline-Directed Medical Therapy (GDMT)?
GDMT is the set of medications proven by large clinical trials to extend life and prevent hospitalizations in cardiovascular disease. For heart failure, that includes the modern "four pillars" — ACE inhibitors or ARBs (or ARNI), beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors — each at the right dose. The phrase "guideline-directed" matters because the benefit comes not just from being on a drug, but from being on the right combination at the right target dose.
Why is optimization of GDMT so important?
Most patients with heart failure or coronary disease are technically on "a" medication regimen but aren't on optimal doses of every appropriate drug. Real-world data consistently show that fully optimized GDMT meaningfully reduces hospitalizations and death compared with partial regimens. Dr. Kedan's job is to close that gap — patient by patient, visit by visit — until you're on the most protective combination you can tolerate.
How does Dr. Kedan decide which medications I should be on?
Decisions follow the most current ACC, AHA, and ESC guidelines, then get individualized for your blood pressure, kidney function, heart rhythm, ejection fraction, and side-effect history. Each medication is matched to a specific physiologic problem rather than added by reflex. The plan is written down so you understand why each pill exists.
What conditions does GDMT typically apply to?
GDMT pathways exist for heart failure with reduced or preserved ejection fraction, coronary artery disease and post-stent or post-bypass care, atrial fibrillation, hypertension, and secondary prevention after a heart attack. If you carry one of these diagnoses, there is almost certainly a guideline-based regimen that can be sharpened. Schedule a consultation with Dr. Kedan to review where your current regimen sits against the latest evidence.
How long does it take to get to optimal doses?
Titration usually takes weeks to a few months, with dose increases every 1–2 weeks when tolerated and labs rechecked along the way. The concierge model speeds this up substantially — questions get answered the same day and dose changes don't have to wait for the next available slot. Most patients reach target doses faster here than in a conventional practice.
What side effects should I watch for?
Common issues include lightheadedness, slow heart rate, cough, elevated potassium, or changes in kidney function — most of which are manageable with dose or timing adjustments. Dr. Kedan monitors labs closely during titration and reassesses with each visit so problems are caught early. If a specific medication isn't tolerated, there is almost always an alternative within the same guideline-directed class.
Will I have to take these medications forever?
In most cardiovascular conditions, yes — the benefit of GDMT comes from continuous protection, and stopping medications generally returns risk to baseline. For some patients with significant recovery (such as improved heart failure ejection fraction), regimens can sometimes be simplified, but only after careful evaluation. Decisions to stop or reduce therapy are made together and rarely abruptly.
How is medication adherence supported?
Adherence is treated as a clinical issue, not a willpower issue. Dr. Kedan reviews the regimen at every visit, simplifies dosing where possible, addresses side effects promptly, and explains the "why" behind each medication so you have a reason to take it. Direct physician communication between visits — without a phone tree — also makes it easier to flag a problem before you stop a drug on your own.
Is GDMT management covered by insurance?
Cardiolucent does not accept Medicare or insurance and bills patients directly for visits; we provide a detailed superbill for out-of-network reimbursement. The medications themselves are typically prescribed through your pharmacy and run through your prescription drug coverage as usual. Call (310) 304-5555 if you have specific billing questions.

Explore

Related Services

Ready to learn more about Guideline-Directed Medical Therapy (GDMT) for Cardiovascular Disease?

Schedule a private consultation with Dr. Kedan in Beverly Hills.
Schedule an Appointment

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

†Some listed indications involve investigational/off-label use. Learn more.